Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.86 USD | +9.78% |
|
+25.16% | -43.62% |
07-09 | RBC Cuts Price Target on Verve Therapeutics to $25 From $35, Keeps Outperform, Speculative Risk | MT |
06-28 | Verve Therapeutics, Inc. Announces Board and Committee Appointments | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
660M | - | |||||
47.96B | - | |||||
41.47B | ||||||
42.45B | ||||||
31.6B | - | |||||
28.63B |